Grassberger M - Search Results

1

Pimecrolimus: skin disposition after topical administration in minipigs in vivo and in human skin in vitro.

Gschwind HP, Waldmeier F, Zollinger M, Schweitzer A, Grassberger M. Gschwind HP, et al. Among authors: grassberger m. Eur J Pharm Sci. 2008 Jan;33(1):9-19. doi: 10.1016/j.ejps.2007.09.004. Epub 2007 Sep 22. Eur J Pharm Sci. 2008. PMID: 17996430

2

Pimecrolimus: absorption, distribution, metabolism, and excretion in healthy volunteers after a single oral dose and supplementary investigations in vitro.

Zollinger M, Waldmeier F, Hartmann S, Zenke G, Zimmerlin AG, Glaenzel U, Baldeck JP, Schweitzer A, Berthier S, Moenius T, Grassberger MA. Zollinger M, et al. Among authors: grassberger ma. Drug Metab Dispos. 2006 May;34(5):765-74. doi: 10.1124/dmd.105.007732. Epub 2006 Feb 7. Drug Metab Dispos. 2006. PMID: 16467136

3

Pimecrolimus -- an anti-inflammatory drug targeting the skin.

Grassberger M, Steinhoff M, Schneider D, Luger TA. Grassberger M, et al. Exp Dermatol. 2004 Dec;13(12):721-30. doi: 10.1111/j.0906-6705.2004.00269.x. Exp Dermatol. 2004. PMID: 15560755 Review.

4

Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.

Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG. Stuetz A, et al. Among authors: grassberger m. Int Arch Allergy Immunol. 2006;141(3):199-212. doi: 10.1159/000095289. Epub 2006 Aug 22. Int Arch Allergy Immunol. 2006. PMID: 16926539 Review.

5

Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.

Stuetz A, Grassberger M, Meingassner JG. Stuetz A, et al. Among authors: grassberger m. Semin Cutan Med Surg. 2001 Dec;20(4):233-41. doi: 10.1053/sder.2001.29066. Semin Cutan Med Surg. 2001. PMID: 11770910 Review.

6

[Development and pre-clinical aspects of pimecrolimus].

Stütz A, Grassberger M, Meingassner JG. Stütz A, et al. Among authors: grassberger m. Hautarzt. 2003 May;54(5):405-12. doi: 10.1007/s00105-003-0519-0. Epub 2003 Apr 5. Hautarzt. 2003. PMID: 12719859 German.

7

A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology.

Meingassner JG, Grassberger M, Fahrngruber H, Moore HD, Schuurman H, Stütz A. Meingassner JG, et al. Among authors: grassberger m. Br J Dermatol. 1997 Oct;137(4):568-76. doi: 10.1111/j.1365-2133.1997.tb03788.x. Br J Dermatol. 1997. PMID: 9390333

8

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology.

Grassberger M, Baumruker T, Enz A, Hiestand P, Hultsch T, Kalthoff F, Schuler W, Schulz M, Werner FJ, Winiski A, Wolff B, Zenke G. Grassberger M, et al. Br J Dermatol. 1999 Aug;141(2):264-73. doi: 10.1046/j.1365-2133.1999.02974.x. Br J Dermatol. 1999. PMID: 10468798

9

Pimecrolimus: a review of pre-clinical and clinical data.

Graham-Brown RA, Grassberger M. Graham-Brown RA, et al. Among authors: grassberger m. Int J Clin Pract. 2003 May;57(4):319-27. Int J Clin Pract. 2003. PMID: 12800465 Review.

10

Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight.

Billich A, Vyplel H, Grassberger M, Schmook FP, Steck A, Stuetz A. Billich A, et al. Among authors: grassberger m. Bioorg Med Chem. 2005 May 2;13(9):3157-67. doi: 10.1016/j.bmc.2005.02.049. Bioorg Med Chem. 2005. PMID: 15809151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters